Literature DB >> 3553239

Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern.

H M Lokhorst, S E Boom, B J Bast, P J Peters, T F Tedder, J Gerdes, E Petersen, R E Ballieux.   

Abstract

We examined bone marrow from myeloma patients for the presence of cells with the characteristics of the clonogenic cell in the myeloma stem cell assay. We identified a novel type of cell that contained cytoplasmic immunoglobulin of the relevant idiotype located in a cytoplasmic spot. This "spotted" Ig could be located in the rough endoplasmic reticulum. Spotted cells are highly proliferative, as evidenced by the nuclear staining with the antibody Ki67, and were found in the bone marrow from most of the myeloma patients studied. This type of cell was also present in patients with immunocytomas, in some cases of benign monoclonal gammopathy, and in patients in the state of polyclonal hypergammaglobulinemia. IgG subclass distribution of so-called spotted cells and plasma cells, found in a patient with pseudo biclonal gammopathy, indicates that spotted cells are intermediate between B cells and plasma cells. Spotted cells express the B cell-associated antigens HB4 and HB6 but do not express other B cluster of differentiation antigens or plasmacytoid antigens tested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553239      PMCID: PMC424404          DOI: 10.1172/JCI112968

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Monoclonal antibodies that bind to the human erythrocyte-membrane glycoproteins glycophorin A and Band 3 [proceedings].

Authors:  P A Edwards
Journal:  Biochem Soc Trans       Date:  1980-06       Impact factor: 5.407

2.  Characterization of a human B cell-specific antigen (B2) distinct from B1.

Authors:  L M Nadler; P Stashenko; R Hardy; A van Agthoven; C Terhorst; S F Schlossman
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

3.  Primary bioassay of human myeloma stem cells.

Authors:  A Hamburger; S E Salmon
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

4.  Ia antigen expression by human malignant lymphomas: correlation with conventional lymphoid markers.

Authors:  J P Halper; D M Knowles; C Y Wang
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

5.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Monoclonal lymphocyte population in human plasma cell myeloma.

Authors:  H Mellstedt; S Hammarström; G Holm
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

7.  Determination of the plasma cell labelling index with bromodeoxyuridine in a double fluorescence technique.

Authors:  H M Lokhorst; S E Boom; B J Bast; R E Ballieux
Journal:  Br J Haematol       Date:  1986-10       Impact factor: 6.998

8.  Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.

Authors:  D A Brooks; I G Beckman; J Bradley; P J McNamara; M E Thomas; H Zola
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

9.  Use of colloidal gold particles in double-labeling immunoelectron microscopy of ultrathin frozen tissue sections.

Authors:  H J Geuze; J W Slot; P A van der Ley; R C Scheffer
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

10.  Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.

Authors:  H Kubagawa; L B Vogler; J D Capra; M E Conrad; A R Lawton; M D Cooper
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  4 in total

1.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase.

Authors:  B J Bast; L J Zhou; G J Freeman; K J Colley; T J Ernst; J M Munro; T F Tedder
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

3.  An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.

Authors:  A Dinota; L Barbieri; M Gobbi; P L Tazzari; S Rizzi; A Bontadini; A Bolognesi; S Tura; F Stirpe
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

4.  Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum.

Authors:  C Valetti; C E Grossi; C Milstein; R Sitia
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.